Both in vivo (CIA rat model) and in vitro (human RA-FLSs) studies demonstrated increased expression of the deubiquitinating enzyme USP2, further implicating its involvement in RA progression [31]. The gene discussed is USP2; the disease is rheumatoid arthritis.